Triple antithrombotic therapy for atrial fibrillation and coronary stents

被引：0
|
作者：
Shmyr, Danielle [1 ]
Van der Merwe, Vanessa [2 ]
Yakiwchuk, Erin [2 ,3 ]
Barry, Arden [4 ,5 ]
Kosar, Lynette [6 ,7 ]
机构：
[1] Saskatoon Hlth Reg, Saskatoon, SK, Canada
[2] Saskatoon Hlth Reg, Geriatr Evaluat & Management Program, Saskatoon, SK, Canada
[3] Saskatoon Hlth Reg, Pharm Dept, Saskatoon, SK, Canada
[4] Chilliwack Gen Hosp, Lower Mainland Pharm Serv, Chilliwack, BC, Canada
[5] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[6] Saskatoon Hlth Reg, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[7] Univ Saskatchewan, Coll Pharm, Saskatoon, SK, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2017年 / 63卷 / 05期
关键词：
PROTON PUMP INHIBITORS; PERCUTANEOUS CORONARY; ANTIPLATELET THERAPY; FOCUSED UPDATE; CLOPIDOGREL; IMPLANTATION; MANAGEMENT; APIXABAN; DURATION; REGIMENS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：375 / 381
页数：7
相关论文
共 50 条
  • [1] Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents
    Paikin, Jeremy S.
    Wright, Douglas S.
    Crowther, Mark A.
    Mehta, Shamir R.
    Eikelboom, John W.
    CIRCULATION, 2010, 121 (18) : 2067 - 2070
  • [2] Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents
    Paikin, Jeremy S.
    Mehta, Shamir R.
    Eikelboom, John W.
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (09) : 487 - 488
  • [3] Triple Therapy or Triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents
    Francescone, Steven
    Halperin, Jonathan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (08) : 826 - 827
  • [4] Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting
    Reed, Grant W.
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2013, 36 (10) : 585 - 594
  • [5] Double Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
    Dharma, Surya
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2020, 29 (02) : 81 - 87
  • [6] Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Kerneis, Mathieu
    Talib, Usama
    Nafee, Tarek
    Daaboul, Yazan
    Pahlavani, Seyedmandi
    Pitliya, Anmol
    Furgan, M. M.
    Datta, Sudarshana
    Kazmi, Hassan A.
    Younes, Ahmed
    Gibson, C. Michael
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 524 - 530
  • [7] Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble
    Massimo Leggio
    Augusto Fusco
    Paolo Severi
    Mario Lombardi
    Elisa Caldarone
    Stefania D’Emidio
    Massimo Armeni
    Daniela Mereu
    Maria Grazia Bendini
    Andrea Mazza
    Drugs, 2018, 78 : 1309 - 1319
  • [8] Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble
    Leggio, Massimo
    Fusco, Augusto
    Severi, Paolo
    Lombardi, Mario
    Caldarone, Elisa
    D'Emidio, Stefania
    Armeni, Massimo
    Mereu, Daniela
    Bendini, Maria Grazia
    Mazza, Andrea
    DRUGS, 2018, 78 (13) : 1309 - 1319
  • [9] DUAL ANTITHROMBOTIC THERAPY VERSUS TRIPLE ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME: A META ANALYSIS
    Hoang Nhat Pham
    Ibrahim, Ramzi
    Sainbayar, Enkhtsogt
    Hickerson, Natalie
    Grewal, Harneet
    Mamas, Mamas A.
    Lee, Kwan S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 41 - 41
  • [10] Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents
    Enomoto Y.
    Iijima R.
    Tokue M.
    Ito N.
    Nagashima Y.
    Araki T.
    Yamazaki K.
    Utsunomiya M.
    Hori M.
    Itaya H.
    Shiba M.
    Hara H.
    Nakamura M.
    Sugi K.
    Cardiovascular Intervention and Therapeutics, 2014, 29 (3) : 193 - 199
12345